I&I biotech cAMPfield attracts top-tier investors in $180M Series A

The money continues to flow for drug development startups that are working on inflammatory and immunology medicines licensed from other companies. A new San Diego biotech called cAMPfield Therapeutics is the latest to secure backing ...